Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Metastasis-related genes]

H Yokozaki¹, E Tahara

¹Dept. of Pathology, Hiroshima University School of Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy

|November 1, 1994

Summary

Genetic alterations drive cancer metastasis. Key factors include hst-1/int-2 co-amplification in esophageal cancer and specific gene amplifications (K-sam, c-erbB2) in gastric cancer metastasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Coamplification of cyclin-d, hst-1 and int-2 genes is a good biological marker of high malignancy for human esophageal carcinomas.

Oncology reports·2011

Same author

Expression of e-cadherin, alpha-catenins and Beta-catenins in human gastric carcinomas - correlation with histology and tumor progression.

Oncology reports·2011

Same author

Increased expression and phosphorylation of sh-ptp2 (syp) in human gastric carcinomas.

Oncology reports·2011

Same author

A splice variant of the c-met proto-oncogene is the predominant population expressed in human gastric mucosa and carcinoma.

Oncology reports·2011

Same author

Genetic abnormalities and expression of p53 in human colon carcinomas.

International journal of oncology·2011

Same author

Biologic effect of human hepatocyte growth-factor on human gastric-carcinoma cell-lines.

International journal of oncology·2011

Area of Science:

Oncology
Molecular Biology
Genetics

Background:

Cancer metastasis is a complex process involving genetic alterations.
Understanding these genetic changes is crucial for developing targeted therapies.
Previous research has identified several genetic factors implicated in metastasis.

Purpose of the Study:

To provide an overview of genetic changes associated with cancer metastasis.
To highlight specific genetic alterations linked to esophageal and gastric carcinoma metastasis.
To discuss the role of cell adhesion molecules and gene expression in cancer spread.

Main Methods:

Review of existing scientific literature on cancer genetics and metastasis.
Analysis of genetic alterations such as gene amplification and expression reduction.
Identification of key molecular pathways and markers involved in metastasis.

Main Results:

hst-1/int-2 co-amplification correlates with metastatic potential in esophageal carcinomas.
Autocrine/paracrine loops (EGF, TGF-alpha/EGF receptor, HGF/c-met) are linked to gastric carcinoma malignancy.
K-sam and c-erbB2 amplification occur in gastric carcinoma metastatic foci.
CD44 splice variants serve as markers for carcinomas and metastases.
Reduced nm23 expression is common in metastasis of various cancers, including stomach and colorectal.

Conclusions:

Specific genetic amplifications and altered gene expression play significant roles in cancer metastasis.
Molecular markers like CD44 variants and nm23 are important in understanding and potentially targeting metastatic processes.
Further research into these genetic factors can lead to improved diagnostic and therapeutic strategies for metastatic cancers.

Related Experiment Videos